Innovator’s Pitch Challenge

Interested in Connecting? Please contact:

Russ Lehrman
Founder & CEO

Message the company or request a 1:1 meeting here

Company Description

Our mission is to revolutionize respiratory care and save lives by curing lung disease. We are developing two technology platforms to achieve this goal. First, we have developed a first-in-class bioengineered lung surfactant (BLS), a key biomaterial that is required for breathing. BLS is itself a treatment, and has also been shown to effectively deliver anti-inflammatory, anti-infective and other important medicines to the lung. We are also using gene therapy to deliver a protein that heals damaged lung tissue. This protein has been shown to increase survival by over 60% in several animal models. We anticipate that our gene therapy platform will be used to treat multiple serious respiratory diseases.

Pitch Deck

Executive Summary